Overview

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine in healthy volunteers whether certain anti-HIV medications (lopinavir/ritonavir and efavirenz) affect the drug levels of certain anti-malarial medications (artesunate/ amodiaquine and artemether/ lumefantrine) and vice versa. Since these drugs are degraded using overlapping pathways in the liver, it is predicted that changes in both drug level and overall drug exposure will be observed.
Phase:
Phase 1
Details
Lead Sponsor:
Fran Aweeka
Treatments:
Anti-Retroviral Agents
Antimalarials
Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Efavirenz
Lopinavir
Lumefantrine
Ritonavir